Forbes Magazine once again rates Nu Skin a buy!
Friday, September 18, 2009 at 01:32PM Nu Skin Enterprises ( NUS - news - people ) uses independent representatives to sell premium cosmetics, personal-care products and nutritional supplements. Already established in North Asia, the company continues to penetrate other markets, including South Asia, Europe and North America, which collectively represented 18% of 2008 sales. Most of Nu Skin's revenue comes from direct sales, a form of social networking that Nu Skin claims performs well when consumer spending contracts.
Recent strong operating results suggest Nu Skin's claims have merit. Per-share earnings were up 16% in the first half of 2009. Operating cash flow has risen in each of the past six quarters to support the annual dividend, currently at $0.46 per share. Shares have surged 70% this year, well above the 13% gain registered by the S&P 1500 Index.
But the stock is reasonably valued and could reach $20 over the next 12 months. At 15 times trailing earnings, the shares trade 21% below the industry average and 15% below the company's three-year average. With a performance score of 82 and overall score of 93, Nu Skin is a buy.
Read the article here
Forbes,
NUS,
Nu Skin,
Reinhard Mulller,
stock exchange 


Reader Comments (3)
cisco
Reinhard
i cannot find Nu Skin from the link. there's only Avon, amway, and herbalife.
consider also, that the author might be a distributor of Glimpse.
Nu Skin is part of human genome project. they can not hurt humans. :)